IRadimed Corporation

IRadimed Corporation

IRMD

$85.08

Updated: 22/09/2026, 20:39:46

Market Cap
$1.09B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for IRMD
Company Profile

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.

USD
NASDAQ
CEO: Roger E. Susi
Employees: 166
https://www.iradimed.com
Asset Summaries
Latest generated summaries for IRMD

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for IRMD.
Share price
$85.08
Market cap
$1.09B
Exchange
NASDAQ
Currency
USD
CEO
Roger E. Susi
Employees
166
IPO date
16/07/2014
Beta
0.899
Last dividend
$0.00
Day range
$81.98 – $85.57
52-week range
$67.84 – $107.90
1-day performance
3.18%
1-year performance
25.41%
Current drawdown (1Y)
-21.15%
CIK
0001325618
CUSIP
46266A109
ISIN
US46266A1097
Created
07/12/2025, 04:46:31
Last update
22/09/2026, 20:39:46

Track IRadimed Corporation with an AI analyst

See which prediction-market events move IRMD, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.